SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Misonix Inc. (MSON)
MSON 26.540.0%Nov 22 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: md1derful who wrote (519)10/31/1997 4:18:00 PM
From: puzzlecraft  Read Replies (1) of 947
 
doctor wonderful,

The link at smartmoney.com

says that "Ted Flomenhaft, an analyst with L. Flomenhaft Co., and the
only analyst that follows the company, had estimated Misonix would earn 14 cents a share for the quarter ended Sept. 30." and that "Flomenhaft previously estimated Misonix would earn 30 cents a share, on a presplit basis."

So part of MSON's fall must have occurred when Ted lowered his post-split estimate from 20 cents to 14 cents. Does anybody know when this occurred? I don't buy the argument that the announced split had something to do with the fall.

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext